Management of Transfusion‐Dependent Thalassaemia Patients in Emergency Situations
Management of Transfusion‐Dependent Thalassaemia Patients in Emergency Situations
复制标题
紧急情况下输血依赖性地中海贫血患者的管理
DOI:
10.1111/jpc.16206
复制
发表时间:
2022
影响因子:
1.7
通讯作者:
Ariyoshi Koya
中科院分区:
文献类型:
--
作者:
Aoki Yoshihiro;Smith Chris;Ariyoshi Koya
Parakh et al. recently conducted a prospective observational study on the impact of the Covid-19 pandemic and the associated lockdown on the care of transfusion-dependent thalassemia (TDT) patients in North India. 1 They reported significantly lower mean pretransfusion hemoglobin levels during and post-lockdown compared to pre-lockdown. They also described the countermeasures of the thalassemia outpatient clinic to address the various issues of Covid-19. Similar difficulties in clinic accessibility and declined donor blood can occur outside of the Covid-19 pandemic, such as in conflict settings. 2 However, the impact of these disruptions on long-term clinical outcomes of thalassemia patients is not clear. Further consideration should be given to potential harm as a consequence of treatment disruption for TDT patients. Whether a pre-transfusion hemoglobin target of 9-10.5 g/dL is optimal for thalassemia treatment in emergencies is debatable. Maintenance of a certain hemoglobin level is vital in TDT patients because anemia contributes to extramedullary hematopoiesis, exacerbates splenomegaly, and increases hemolysis. On the other hand, hypertransfusion maintaining baseline hemoglobin at 10-12 g/dL contributes to iron overload and significantly affects delayed puberty, so moderate transfusion aiming for 9-10 g/dL has been considered better without causing extramedullary hematopoiesis. 3 However, when considering population outcomes in situations of insufficient
影响因子:
0.5
作者:
Wiwanitkit, Somsri;Wiwanitkit, Viroj
通讯作者:
Wiwanitkit, Viroj